Company profile: AbbVie
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for pharmaceutical companies across small and large molecules and biologics. Offerings include aseptic fill-finish of parenteral vials and prefilled syringes; biologics and antibody-drug conjugate manufacturing; API process optimization, tech transfer, and analytical development; turnkey ophthalmic filling and packaging; hot melt extrusion to improve API solubility and bioavailability; and microbial fermentation for API process development and commercial manufacturing.
Products and services
- Biologics Contract Manufacturing: Architects large‑molecule programs, including antibody‑drug conjugates, supporting manufacturing with a strong focus on quality and operational efficiency for demanding biologics portfolios
- Active Pharmaceutical Ingredients (APIs) Contract Manufacturing: Engineers process‑optimized production for small‑ and large‑molecule APIs, integrating technology transfer and analytical development to advance robust, efficient API manufacturing
- Aseptic Fill Finish Manufacturing: Delivers multi‑format parenteral fill‑finish for vials and pre‑filled syringes, ensuring sterile transfer and packaging for parenteral drug products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AbbVie
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
Eurofins
HQ: Luxembourg
Website
- Description: Provider of analytical testing and support services across pharmaceutical, food, environmental, and consumer products industries, including clinical diagnostics (sample collection, testing, counseling), environmental testing of water, air, soil and waste, cosmetics and personal care compliance testing, E&E product safety and approvals, maritime pollution and fuel/oil testing, and microbiological testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurofins company profile →
Polydex Pharmaceuticals
HQ: Canada
Website
- Description: Provider of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, manufacturing and selling dextran and derivative products to large pharmaceutical companies globally. Under a definitive supply agreement with Sparhawk in the United States, provides ferric hydroxide and hydrogenated dextran through its U.S. subsidiary, Chemdex.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Polydex Pharmaceuticals company profile →
Locust Walk
HQ: United States
Website
- Description: Provider of strategic partnering and M&A services, facilitating licensing and acquisition deals in the USA, Europe, Japan, and China. Offers capital raising and underwriting, including private placements, IPO advisory, and SPAC advisory. Delivers strategy consulting and analytics for partnering, M&A, and fundraising. Conducts rigorous due diligence via internal committee and external scientific advisory board.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Locust Walk company profile →
Genflow Biosciences
HQ: United States
Website
- Description: Provider of synthetic biology-based gene therapies to delay or stop aging in humans and dogs, focused on the development and promotion of creative treatments that target aging to extend life expectancy in both humans and canines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genflow Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AbbVie
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AbbVie
2.2 - Growth funds investing in similar companies to AbbVie
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AbbVie
4.2 - Public trading comparable groups for AbbVie
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →